Patently Innovative

How Pharmaceutical Firms Use Emerging Patent Law to Extend Monopolies on Blockbuster Drugs

R A Bouchard (Autor)

Buch | Hardcover

296 Seiten

2012
Woodhead Publishing Ltd (Verlag)
978-1-907568-12-1 (ISBN)

Titel z.Zt. nicht lieferbar
Versandkostenfrei
Auch auf Rechnung

Artikel merken

Patently innovative provides a review of the importance of traditional patent law and emerging linkage regulations for pharmaceutical products on the global stage, with a focus on the linkage regime in Canada. The primary focus is on how innovation in the pharmaceutical sector can be strongly regulated and how government regulation can either stimulate or inhibit development of breakthrough products.

Dr Ron A. Bouchard is an intellectual property lawyer and scholar, specializing in the innovation, regulation, and litigation of biomedical products. His career has focused on the science, law, policy, regulation, and commercialization of medical technologies. He began his career as a medical scientist, completing a PhD and Postdoctoral Fellowship in the field of ion channel biophysics and Ca2+ imaging. He shifted focus to obtain a law degree specializing in pharmaceutical and biotechnology law and has been involved in the prosecution, acquisition, financing, distribution, and litigation of intellectual property rights. Dr Bouchard has appeared before the Federal Court of Canada and the Supreme Court of Canada. He has consulted with firms, universities, governments, and international organizations on legal, regulatory, and policy issues. He worked with the Government of Canada on its platforms for drug regulation and public private partnerships in technology commercialization. His research has been funded by federal and provincial funding agencies and private endowments. His scholarly expertise is focused on the intellectual property and regulatory aspects of therapeutic product development, including global aspects of technology commercialization, patenting, licensing, and regulatory approval, and empirical assessment of the impact of government stimulus packages and regulation on technology innovation. Dr Bouchard currently is involved with a new global consortium of scholars, physicians and economists studying the impact of emerging forms of patent law on the availability and costs of essential medications in developed and developing nations: the Consortium Study of Global Pharmaceutical Linkage.

Dedication

Acknowledgements

List of figures and tables

List of abbreviations

About the author

Chapter 1: Introduction

Abstract:

1.1 The emergence of global pharmaceutical linkage

1.2 Canadian pharmaceutical linkage regulations

1.3 Organization

Chapter 2: Background: drug approval, drug patenting, pharmaceutical linkage, and public health policy

Abstract:

2.1 Drug approval

2.2 Patents

2.3 Linkage regulations

2.4 IPR rights and innovation policy

Chapter 3: Empirical analysis of drug approval

Abstract:

3.1 Introduction

3.2 Analysis

3.3 Results

3.4 Discussion

3.5 Interpretation of data

3.6 Study limitations

3.7 Assessing the lifecycle approach: the long view

3.8 Government as representative public agent

3.9 Summary and conclusions

Chapter 4: Empirical analysis of pharmaceutical innovation and drug approval-drug patenting linkage

Abstract:

4.1 Introduction

4.2 Methods

4.3 Results

4.4 Discussion

Chapter 5: Empirical analysis of drug patenting in multiple high-value cohorts

Abstract:

5.1 Introduction

5.2 Methods

5.3 Results

5.4 Discussion

5.5 Summary and conclusions

Chapter 6: Implications of empirical data: are pharmaceutical linkage regulations a success?

Abstract:

6.1 Introduction

6.2 Debate preceding Bill C-91

6.3 ‘Original policy intent’

6.4 ‘Patent-specific’ analysis

6.5 Statutory interpretation

6.6 Revisiting the empirical data

6.7 Summary and conclusions

Chapter 7: Future directions: testable hypotheses and evolution toward global pharmaceutical linkage

Abstract:

7.1 Hypotheses regarding cluster-based drug development

7.2 Globalization of pharmaceutical linkage

Index

Erscheint lt. Verlag	2.1.2012
Reihe/Serie	Woodhead Publishing Series in Biomedicine
Verlagsort	Cambridge
Sprache	englisch
Maße	156 x 234 mm
Gewicht	780 g
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
	Medizin / Pharmazie ► Pharmazie
	Recht / Steuern ► EU / Internationales Recht
	Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Medizinrecht
	Recht / Steuern ► Wirtschaftsrecht ► Urheberrecht
	Technik
ISBN-10	1-907568-12-3 / 1907568123
ISBN-13	978-1-907568-12-1 / 9781907568121
Zustand	Neuware